ArticleClinical and translational medicine2017
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes.
Brian M Necela et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this paperpooled itcites it